Vaishali Pharma Quarterly Results for Trading Insights

In Sept 2025, Vaishali Pharma (VAISHALI) reported revenue ₹34 Cr and net profit ₹1 Cr. For annual financials, live price and key ratios, visit VAISHALI stock price BSE.

Latest Quarter Net Profit
₹1 Cr
QSept 2025
Quarterly Results

VAISHALI Quarterly Results — Revenue, Profit & EPS Highlights

Vaishali Pharma latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with Vaishali Pharma value estimation to assess whether the stock is under or overvalued.

  • Revenue of ₹34 Cr in Sept 2025 (+36.0% vs Jun 2025)
  • Net Profit of ₹1 Cr in Sept 2025 (+0.0% vs Jun 2025)
  • EBITDA of ₹2 Cr in Sept 2025 (+0.0% vs Jun 2025)
  • Operating Margin of 4.0% in Sept 2025 (-2.0pp vs Jun 2025)
  • Earnings Per Share of ₹0.09 in Sept 2025 (-10.0% vs Jun 2025)

Vaishali Pharma Quarterly Results — Revenue, EBITDA, Net Profit & EPS

VAISHALI quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 34 25 36.0% -
Net Profit (₹ Cr) 1 1 - -
EBITDA (₹ Cr) 2 2 - -
EPS (₹) 0.09 0.10 - -
Operating Margin (%) 4.0% 6.0% - -

VAISHALI Share Price Trend — 1-Year Movement Across Quarterly Results

Vaishali Pharma 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse Vaishali Pharma ownership structure to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin 2.9%
EBITDA Margin 5.9%
Operating Margin 4.0%
ROE (Annual) 6.2%

Balance Sheet Highlights

Total Assets ₹110 Cr
Total Equity ₹65 Cr
Current Assets ₹105 Cr
Current Liabilities ₹5 Cr

Cash Flow Analysis

Operating Cash Flow ₹-18 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹19 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹7.71
Exchange NSE
Last Updated Apr 17, 2026

Revenue Trend (₹ Cr)

Jun 2025 25
Sept 2025 34

Net Profit Trend (₹ Cr)

Jun 2025 1
Sept 2025 1

Operating Margin Trend (%)

Jun 2025 6.0%
Sept 2025 4.0%

VAISHALI vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Vaishali Pharma latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹396,418.12 Cr 1675.5 14,875 3,125 +10.8% - 21.0% 128.9
Divis Laboratories
Sept 2025 		₹161,139.43 Cr 6229.0 2,860 689 +7.1% - 24.1% 239.9
Torrent Pharmaceuti…
Sept 2025 		₹140,630.85 Cr 4179.5 3,219 591 +11.3% - 18.4% 238.3
Lupin
Sept 2025 		₹106,664.75 Cr 2326.1 6,921 1,485 +23.2% - 21.5% 71.9
Dr Reddys Laborator…
Sept 2025 		₹103,153.53 Cr 1235.7 9,135 1,337 +1.1% - 14.6% 76.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores